NO Europe · Source: DMP (Norwegian Medical Products Agency)
Medicine shortages in Norway
As of 2 Nov 2026, 309 products have a reported shortage in Norway, across 172 active ingredients.
Scope: Ongoing and announced shortages reported by companies; one row per pack (varenummer). Official list.
Products short309today
Per million people55.2population ≈ 5.6 m
Medicines172active ingredients
New in 30 days54reported start
Typical duration4 monthsmedian so far
No return date1%of products
When today's shortages began
8 started before Dec 2024Current shortages by the month they were reported to start. A tall recent bar means a new wave.
How long they have lasted
When products are expected back
2 products have no return date.
Why medicines are short
Which therapeutic classes
Companies with the most products short
Compared with other countries
Registers differ in scope, so treat this as a rough comparison.
Typical duration vs other countries
All 171 medicines short in Norway
| Medicine | Products | Earliest start | Latest expected back | Main reason | Countries |
|---|---|---|---|---|---|
| Acetylcysteine | 1 | 25 Aug 2026 | 24 Nov 2026 | Distribution or logistics | |
| Aflibercept | 2 | 16 Oct 2026 | 30 Sep 2027 | Commercial decision or withdrawal | |
| Alimemazine | 1 | 19 Jun 2026 | 4 Dec 2026 | Manufacturing problem | |
| Amitriptyline | 1 | 26 Oct 2026 | 30 Nov 2026 | Regulatory or licensing | |
| Amoxicillin | 1 | 30 Jun 2026 | 2 Nov 2026 | Manufacturing problem | |
| Anidulafungin | 1 | 1 May 2026 | 31 Dec 2026 | Manufacturing problem | |
| Antilymphocyte Immunoglobulin (Horse) | 1 | 30 Jul 2026 | 6 Nov 2026 | Manufacturing problem | |
| Aprepitant | 2 | 28 Feb 2025 | 31 Jan 2028 | Increased demand | |
| Artificial Tears and Other Indifferent Preparations | 1 | 1 Jan 2025 | 30 Nov 2027 | Manufacturing problem | |
| Atomoxetine | 6 | 3 Jul 2026 | 31 Dec 2027 | Manufacturing problem | |
| Atorvastatin | 2 | 31 Aug 2026 | 22 Jan 2027 | Manufacturing problem | |
| Atosiban | 2 | 9 Jul 2025 | 31 Dec 2026 | Manufacturing problem | |
| Aztreonam | 1 | 3 Jul 2026 | 30 Jun 2027 | Manufacturing problem | |
| Betamethasone | 1 | 19 Dec 2026 | 14 Feb 2027 | Manufacturing problem | |
| Betamethasone | 1 | 23 Nov 2026 | 1 Dec 2026 | Commercial decision or withdrawal | |
| Bosentan | 1 | 31 Jul 2026 | 30 Nov 2026 | Manufacturing problem | |
| Bromfenac | 1 | 22 Oct 2026 | 31 Jan 2027 | Increased demand | |
| Budesonide | 1 | 15 Nov 2026 | 11 Dec 2026 | Increased demand | |
| Buprenorphine | 3 | 27 Jul 2026 | 30 Nov 2026 | Distribution or logistics | |
| Buprenorphine, Combinations | 5 | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal | |
| Bupropion | 2 | 7 Feb 2025 | 1 Feb 2027 | Manufacturing problem | |
| Butylscopolamine | 1 | 18 Aug 2026 | 31 Dec 2026 | Increased demand | |
| Cabergoline | 1 | 16 Nov 2026 | 17 Jan 2027 | Increased demand | |
| Capecitabine | 2 | 1 Jun 2026 | 14 Jan 2027 | Manufacturing problem | |
| Chikungunya, Live Attenuated | 2 | 31 Dec 2026 | 31 Dec 2028 | Commercial decision or withdrawal | |
| Chloramphenicol | 1 | 6 Jul 2026 | 31 Dec 2026 | Manufacturing problem | |
| Chlorhexidine | 2 | 1 Apr 2026 | 31 Dec 2026 | Commercial decision or withdrawal | |
| Ciclosporin | 1 | 5 Oct 2026 | 31 Dec 2026 | Manufacturing problem | |
| Codeine and Paracetamol | 4 | 16 Sep 2026 | 19 Nov 2026 | Manufacturing problem | |
| Colecalciferol | 2 | 2 Nov 2025 | 8 Dec 2026 | Commercial decision or withdrawal | |
| Colestyramine | 1 | 11 Mar 2026 | 31 Dec 2026 | Distribution or logistics | |
| Colistin | 1 | 17 Oct 2023 | 2 Mar 2030 | Commercial decision or withdrawal | |
| Cyclizine | 1 | 20 Oct 2025 | 31 Jan 2027 | Regulatory or licensing | |
| Dabigatran Etexilate | 6 | 1 Oct 2026 | 1 Dec 2026 | Commercial decision or withdrawal | |
| Dacarbazine | 1 | 31 Oct 2026 | 15 Dec 2026 | Manufacturing problem | |
| Darunavir | 2 | 11 Jul 2025 | 26 Nov 2026 | Manufacturing problem | |
| Dasatinib | 1 | 30 Sep 2026 | 2 Dec 2026 | Distribution or logistics | |
| Desloratadine | 1 | 31 May 2025 | 1 Dec 2030 | Commercial decision or withdrawal | |
| Desmopressin | 1 | 25 Sep 2026 | 31 Dec 2026 | Commercial decision or withdrawal | |
| Diazepam | 3 | 1 Aug 2024 | 28 Dec 2026 | Manufacturing problem | |
| Diclofenac | 1 | 27 Nov 2025 | 8 Mar 2027 | Manufacturing problem | |
| Diphtheria-Pertussis-Poliomyelitis-Tetanus | 1 | 22 Dec 2026 | 18 Jan 2027 | Increased demand | |
| Dipyridamole | 1 | 3 Sep 2026 | 21 Dec 2026 | Distribution or logistics | |
| Doxylamine | 1 | 28 Sep 2026 | 11 Nov 2026 | Increased demand | |
| Doxylamine, Combinations | 1 | 26 Oct 2026 | 19 Jan 2027 | Quality problem or recall | |
| Droperidol | 1 | 1 Jan 2026 | 1 Jan 2027 | Commercial decision or withdrawal | |
| Edoxaban | 2 | 28 Oct 2026 | 29 Nov 2026 | Manufacturing problem | |
| Electrolytes | 2 | 21 Sep 2026 | 4 Dec 2026 | Manufacturing problem | |
| Electrolytes with Carbohydrates | 1 | 30 Jun 2026 | 31 Dec 2026 | Commercial decision or withdrawal | |
| Enalapril | 3 | 26 Nov 2025 | 24 Dec 2026 | Manufacturing problem | |
| Enoxaparin | 1 | 20 Nov 2026 | 15 Dec 2026 | Manufacturing problem | |
| Entecavir | 1 | 1 May 2025 | 31 Mar 2027 | Distribution or logistics | |
| Epinephrine | 4 | 14 Jan 2021 | 31 Dec 2027 | Increased demand | |
| Erenumab | 1 | 20 Aug 2026 | 3 Dec 2026 | Increased demand | |
| Erlotinib | 3 | 1 Feb 2026 | 30 Nov 2026 | Increased demand | |
| Ertapenem | 1 | 15 Sep 2026 | 31 Dec 2026 | Increased demand | |
| Erythromycin | 2 | 2 Dec 2024 | 31 Oct 2027 | Regulatory or licensing | |
| Escitalopram | 3 | 26 Oct 2026 | 18 Dec 2026 | Manufacturing problem | |
| Esketamine | 1 | 7 Dec 2026 | 8 Jan 2027 | Distribution or logistics | |
| Estradiol | 7 | 27 Jan 2026 | 31 Dec 2026 | Manufacturing problem | |
| Ethylmorphine | 1 | 16 Nov 2026 | 5 Jan 2027 | Manufacturing problem | |
| Etoricoxib | 1 | 1 Nov 2026 | 30 Nov 2026 | Manufacturing problem | |
| Famotidine, Combinations | 2 | 23 Apr 2026 | 30 Nov 2026 | Quality problem or recall | |
| Fentanyl | 4 | 17 Apr 2026 | 31 Dec 2027 | Commercial decision or withdrawal | |
| Ferrous Sulfate | 1 | 1 Sep 2027 | 2 Apr 2028 | Increased demand | |
| Fibrinogen, Human | 1 | 27 Oct 2026 | 1 Feb 2027 | Increased demand | |
| Finasteride | 2 | 12 Oct 2026 | 21 Feb 2027 | Distribution or logistics | |
| Fingolimod | 1 | 26 Oct 2026 | 27 Nov 2026 | Quality problem or recall | |
| Fluocinolone Acetonide and Antiseptics | 1 | 1 Jul 2025 | 30 Nov 2026 | Manufacturing problem | |
| Fluticasone | 1 | 23 Nov 2026 | 22 Feb 2027 | Increased demand | |
| Fluticasone, Combinations | 2 | 29 Oct 2026 | 6 Nov 2026 | Distribution or logistics | |
| Gabapentin | 2 | 1 Sep 2026 | 15 Dec 2026 | Increased demand | |
| Gadoxetic Acid | 1 | 1 Feb 2027 | 16 Mar 2027 | Manufacturing problem | |
| Gentamicin | 2 | 1 Oct 2026 | 30 Apr 2027 | Manufacturing problem | |
| Glyceryl Trinitrate | 1 | 1 Dec 2026 | 18 Dec 2026 | Increased demand | |
| Hepatitis A, Inactivated, Whole Virus | 1 | 4 Jan 2027 | 31 Jan 2027 | Increased demand | |
| Human Menopausal Gonadotrophin | 2 | 17 Jan 2025 | 31 Aug 2027 | Regulatory or licensing | |
| Hydroxyzine | 2 | 18 Sep 2026 | 14 Dec 2026 | Regulatory or licensing | |
| Icatibant | 1 | 6 Oct 2026 | 16 Nov 2026 | Manufacturing problem | |
| Ifosfamide | 3 | 15 Jan 2026 | 1 Jan 2027 | Manufacturing problem | |
| Insulin Aspart | 2 | 18 Sep 2025 | 1 Mar 2027 | Increased demand | |
| Insulin Lispro | 3 | 1 Sep 2025 | 1 Nov 2027 | Manufacturing problem | |
| Iodixanol | 1 | 2 Sep 2026 | 16 Nov 2026 | Increased demand | |
| Isotretinoin | 2 | 28 Nov 2025 | 31 Jan 2027 | Increased demand | |
| Ivabradine | 1 | 4 Nov 2025 | 31 Dec 2026 | Increased demand | |
| Ketotifen | 3 | 11 Feb 2025 | 1 Feb 2027 | Manufacturing problem | |
| Labetalol | 1 | 15 Jul 2022 | 30 Jan 2028 | Commercial decision or withdrawal | |
| Lanreotide | 1 | 10 Dec 2025 | 31 Dec 2026 | Quality problem or recall | |
| Lanthanum Carbonate | 3 | 31 Aug 2026 | 30 Apr 2027 | Manufacturing problem | |
| Lenalidomide | 2 | 6 Nov 2026 | 31 Dec 2026 | Manufacturing problem | |
| Leuprorelin | 1 | 29 Oct 2026 | 15 Jan 2027 | Manufacturing problem | |
| Levocabastine | 1 | 18 Sep 2026 | 13 Nov 2026 | Manufacturing problem | |
| Levodopa and Decarboxylase Inhibitor | 1 | 15 Sep 2026 | 8 Nov 2026 | Manufacturing problem | |
| Lidocaine | 4 | 1 Oct 2025 | 1 Sep 2030 | Commercial decision or withdrawal | |
| Lidocaine, Combinations | 1 | 26 Oct 2026 | 13 Nov 2026 | Distribution or logistics | |
| Lisdexamfetamine | 1 | 23 Nov 2026 | 10 Dec 2026 | Increased demand | |
| Lisinopril | 3 | 21 Sep 2026 | 20 Dec 2026 | Manufacturing problem | |
| Macrogol, Combinations | 7 | 13 Jul 2026 | 23 Sep 2027 | Manufacturing problem | |
| Mepolizumab | 1 | 19 Oct 2026 | 13 Nov 2026 | Distribution or logistics | |
| Mesalazine | 1 | 16 Oct 2026 | 4 Nov 2026 | Manufacturing problem | |
| Mesna | 1 | 15 Jun 2026 | 1 Dec 2026 | Manufacturing problem | |
| Methylphenidate | 1 | 31 Aug 2026 | 31 Aug 2027 | Commercial decision or withdrawal | |
| Metoclopramide | 1 | 30 Oct 2026 | 6 Jan 2027 | Distribution or logistics | |
| Metoprolol | 1 | 3 Nov 2025 | 14 Nov 2027 | Manufacturing problem | |
| Metronidazole | 1 | 18 May 2026 | 8 Feb 2027 | Manufacturing problem | |
| Minoxidil | 1 | 16 Dec 2024 | 31 Dec 2026 | Manufacturing problem | |
| Montelukast | 1 | 1 Nov 2026 | 31 Jan 2027 | Commercial decision or withdrawal | |
| Moxonidine | 1 | 14 Sep 2026 | 11 Dec 2026 | Increased demand | |
| Multienzymes (Lipase, Protease etc.) | 2 | 15 Oct 2026 | 5 Jan 2027 | Increased demand | |
| Mycophenolic Acid | 1 | 14 Feb 2022 | 31 Dec 2032 | Manufacturing problem | |
| Naproxen | 2 | 15 Apr 2026 | 4 Jan 2027 | Manufacturing problem | |
| Nifedipine | 2 | 1 Oct 2026 | 31 Jan 2027 | Increased demand | |
| Nilotinib | 1 | 13 Oct 2026 | 6 Nov 2026 | Increased demand | |
| Olanzapine | 7 | 18 Mar 2025 | 1 Sep 2027 | Commercial decision or withdrawal | |
| Omeprazole | 1 | 22 Oct 2026 | 15 Dec 2026 | Increased demand | |
| Opium Derivatives and Expectorants | 1 | 22 Jun 2026 | 18 Dec 2026 | Regulatory or licensing | |
| Oxycodone | 3 | 4 Mar 2026 | 31 Dec 2026 | Increased demand | |
| Oxycodone and Naloxone | 2 | 31 Jul 2026 | 30 Jan 2027 | Distribution or logistics | |
| Paliperidone | 4 | 7 Nov 2025 | 31 Dec 2026 | Distribution or logistics | |
| Pantoprazole | 1 | 31 Oct 2026 | 30 Apr 2027 | Commercial decision or withdrawal | |
| Paracetamol | 1 | 14 Dec 2026 | 8 Mar 2027 | Manufacturing problem | |
| Paracetamol, Combinations excl. Psycholeptics | 1 | 21 Sep 2026 | 31 Dec 2026 | Manufacturing problem | |
| Perindopril | 1 | 31 Aug 2026 | 31 Dec 2026 | Quality problem or recall | |
| Piroxicam | 1 | 1 Jul 2026 | 15 Nov 2026 | Manufacturing problem | |
| Plastic IUD with Progestogen | 1 | 25 Feb 2026 | 31 Dec 2026 | Commercial decision or withdrawal | |
| Pneumococcus, Purified Polysaccharides Antigen | 1 | 1 Feb 2026 | 31 Dec 2026 | Commercial decision or withdrawal | |
| Pomalidomide | 2 | 1 Dec 2026 | 31 Mar 2027 | Manufacturing problem | |
| Posaconazole | 1 | 31 Mar 2026 | 1 Dec 2026 | Commercial decision or withdrawal | |
| Prasugrel | 3 | 22 Jan 2025 | 15 Mar 2027 | Commercial decision or withdrawal | |
| Pregabalin | 2 | 20 Jul 2026 | 10 Dec 2026 | Manufacturing problem | |
| Prilocaine, Combinations | 1 | 9 Oct 2026 | 6 Nov 2026 | Manufacturing problem | |
| Probenecid | 1 | 28 Sep 2026 | 13 Jan 2027 | Increased demand | |
| Proguanil and Atovaquone | 1 | 1 Dec 2026 | 1 Jul 2027 | Manufacturing problem | |
| Quetiapine | 15 | 25 Aug 2023 | 31 Dec 2027 | Manufacturing problem | |
| Raloxifene | 1 | 1 May 2025 | 31 Aug 2027 | Commercial decision or withdrawal | |
| Remifentanil | 1 | 1 Mar 2026 | 31 Dec 2026 | Commercial decision or withdrawal | |
| Rifampicin | 3 | 16 Mar 2026 | 3 May 2027 | Manufacturing problem | |
| Rifampicin and Isoniazid | 1 | 16 Mar 2026 | 20 Dec 2026 | Manufacturing problem | |
| Salbutamol | 3 | 6 Jan 2026 | 31 Dec 2027 | Manufacturing problem | |
| Salmeterol and Fluticasone | 1 | 9 Sep 2026 | 27 Nov 2026 | Manufacturing problem | |
| Saxagliptin | 1 | 8 Dec 2025 | 1 Feb 2027 | Commercial decision or withdrawal | |
| Selenium (75Se) Tauroselcholic Acid | 1 | 24 Dec 2026 | 8 Jan 2027 | Commercial decision or withdrawal | |
| Sevelamer | 2 | 10 Aug 2026 | 23 Nov 2026 | Manufacturing problem | |
| Sildenafil | 1 | 19 Oct 2026 | 13 Nov 2026 | Increased demand | |
| Silicones | 2 | 13 Aug 2026 | 30 Nov 2026 | Increased demand | |
| Sorafenib | 1 | 31 Jul 2026 | 31 Dec 2026 | Commercial decision or withdrawal | |
| Sufentanil | 1 | 31 Jul 2026 | 1 May 2028 | Commercial decision or withdrawal | |
| Sumatriptan | 4 | 3 Aug 2026 | 8 Jan 2027 | Manufacturing problem | |
| Tadalafil | 5 | 10 Apr 2026 | 5 Feb 2027 | Manufacturing problem | |
| Tamsulosin and Dutasteride | 1 | 28 Dec 2026 | 28 Jan 2027 | Increased demand | |
| Tapentadol | 1 | 28 Jan 2026 | 28 Jan 2030 | Commercial decision or withdrawal | |
| Technetium (99mTc) Antigranulocyte Antibody | 1 | 17 Sep 2025 | 26 Jun 2028 | Manufacturing problem | |
| Tetracycline | 1 | 25 Apr 2025 | 31 Mar 2027 | Active ingredient shortage | |
| Thiosulfate | 1 | 12 Oct 2026 | 30 Nov 2026 | Quality problem or recall | |
| Thiotepa | 2 | 1 Oct 2026 | 15 Mar 2027 | Increased demand | |
| Timolol, Combinations | 3 | 21 Aug 2025 | 31 Dec 2028 | Manufacturing problem | |
| Tolterodine | 2 | 30 Jan 2026 | 10 Mar 2027 | Increased demand | |
| Topotecan | 3 | 8 Jun 2026 | 31 Mar 2027 | Commercial decision or withdrawal | |
| Trabectedin | 1 | 1 Dec 2026 | not given | Manufacturing problem | |
| Trastuzumab | 2 | 30 Jun 2026 | 11 Nov 2026 | Manufacturing problem | |
| Triamcinolone | 2 | 24 Mar 2026 | 31 Mar 2027 | Manufacturing problem | |
| Trometamol | 1 | 26 Oct 2026 | 1 May 2027 | Regulatory or licensing | |
| Valaciclovir | 1 | 13 Jul 2026 | 30 Nov 2026 | Increased demand | |
| Valsartan | 1 | 24 Sep 2026 | 5 Nov 2026 | Increased demand | |
| Vardenafil | 1 | 23 Oct 2026 | 11 Jan 2027 | Manufacturing problem | |
| Vericiguat | 1 | 30 Sep 2026 | 15 Jan 2027 | Distribution or logistics | |
| Verteporfin | 1 | 1 Nov 2020 | 31 Dec 2026 | Manufacturing problem | |
| Vinblastine | 1 | 2 Oct 2026 | 31 Mar 2027 | Manufacturing problem | |
| Vinflunine | 1 | 1 Sep 2026 | 1 May 2027 | Manufacturing problem | |
| Zoledronic Acid | 1 | 3 Aug 2026 | 1 Dec 2026 | Manufacturing problem | |
| Zopiclone | 1 | 5 Oct 2026 | 12 Dec 2026 | Regulatory or licensing |